FDA FAERS Reports on SSRIs Since January 2000 – Citalopram, Fluoxetine, Paroxetine, Sertraline, Etc.

FDA FAERS Reports on SSRIs Since January 2000 – Citalopram, Fluoxetine, Paroxetine, Sertraline, Etc.

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request: • All reports, statistics, or summaries describing the adverse reactions from the use of selective serotonin reuptake inhibitors (SSRIs), including but not limited to the following: Citalopram (Celexa), Escitalopram (Lexapro), Fluoxetine (Prozac, Sarafem, Symbyax), Fluvoxamine (Luvox, Luvox CR), Paroxetine (Paxil, Paxil CR, Pexeva), Sertraline (Zoloft), Vilazodone (Viibryd) and others under similar tradenames, submitted to the FDA Adverse Event Reporting System (FAERS) Public Dashboard by consumers, healthcare representatives, or others, since January 2000 to present.
Tags: Pharma, FAERS, 2000
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details